Invesco S&P 500 Equal Weight Health Care ETF(RSPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RSPH Invesco S&P 500 Equal Weight Health Care ETF

Post-Mkt 10-08 19:42:55 EDT

36.96

-0.04

-0.11%

盘后36.96

+0.000.00%

19:30 EDT

High37.00	Low36.46	Vol257.56K
Open36.81	D1 Closing37.00	Amplitude1.46%
Mkt Cap882.24M	Tradable Cap882.24M	Total Shares23.87M
T/O9.50M	T/O Rate1.08%	Tradable Shares23.87M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.96,"timestamp":1791489600000,"preClose":37,"halted":0,"volume":257557,"hourTrading":{"tag":"盘后","latestPrice":36.96,"preClose":36.96,"latestTime":"19:30 EDT","volume":13,"amount":480.48,"timestamp":1791502204438,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0010810810810810581,"floatShares":23870000,"shares":23870000,"eps":0,"marketStatus":"Post-Mkt","change":-0.04,"latestTime":"10-08 19:42:55 EDT","open":36.81,"high":37,"low":36.46,"amount":9495160.75125,"amplitude":0.014595,"askPrice":40.42,"askSize":100,"bidPrice":33.59,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":37,"sharesOutstanding":23410000,"nav":36.94562,"aum":885217055.2,"dividendRate":0.006001,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":37,"preClose":37,"latestTime":"07:40 EDT","volume":2,"amount":74,"timestamp":1791459651124,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.96,"preClose":36.96,"latestTime":"19:30 EDT","volume":13,"amount":480.48,"timestamp":1791502204438,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.74318,"impliedVol":0.0046,"impliedVolPercentile":0.0757},"requestUrl":"/m/hq/s/RSPH/wiki","defaultTab":"wiki","newsList":[{"id":"2674880548","title":"Health Care Down as Michigan Files Suit Against Insurer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674880548","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674880548?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:28","pubTimestamp":1791494880,"startTime":"0","endTime":"0","summary":"Health-care companies fell amid fears that health insurers would remain in regulatory crosshairs during the election season.Michigan's attorney general filed an antitrust suit against the state's largest health insurer Blue Cross Blue Shield of Michigan, citing monopolistic pricing practices.Among publicly traded health insurers, Humana and UnitedHealth Group lost ground.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1988902786.USD","PINK","MHIP","UNHG","LU1153585028.USD","SUNH0main","RXL","GDOC","LU0053666078.USD","XBI","FXH","LU0820561909.HKD","IE00B894F039.SGD","LU2954938101.SGD","RSPH","FHLC","LU1057294990.SGD","LU0976567544.SGD","LU1732800096.USD","VHT","IE0002141913.USD","LU0158827781.USD","LU0310800965.SGD","IE00B2B36J28.USD","LU0162691827.USD","IXJ","SGXZ51526630.SGD","RXD","LU0011850046.USD","LABU","XLV","JDOC","LU0097036916.USD","SG9999018857.SGD","IYH","LU0072461881.USD","JHMH","LU0211328371.USD","IHF","HRTS","LU0058720904.USD","CURE","TRUH","UN","UNHU","TMED","UNHW","LU0965509010.AUD","UNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178666966","title":"Starbucks Explored Acquisition of Chipotle in Bid to Create Restaurant Industry Mega-Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=1178666966","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178666966?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:20","pubTimestamp":1791469222,"startTime":"0","endTime":"0","summary":"Starbucks held discussions about acquiring Chipotle Mexican Grill, a grand plan that would merge two of America's most recognized consumer brands and, if completed, would rank as the largest merger...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK4610","PSP","BK4504","IYH","BK4209","PRVT","IEFN","DFMC","AAUM","BK4535","ACTV","PBJ","SBUX","BK4588","PEVC","FFSM","PBPH","RFG","MNA","TMED","CANC","EATZ","VXF","LU0882574139.USD","RSPH","BK4585","MMID","TBXU","GTPE","IE00B3T34201.USD","LU0823411888.USD","SBU","UYG","XLFI","BREW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137044188","title":"Shandong Oriental Ocean's Subsidiary Secures Medical Device Registration Certificate for Water-Soluble Vitamin Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1137044188","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137044188?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:48","pubTimestamp":1791449307,"startTime":"0","endTime":"0","summary":"Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) has announced that its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0213","IEIH","HART","BK1100","159883","002086","LNGR","PTH","BK0092","AGNG","BK1574","MEDX","GDOC","LGHT","MDEV","09996","RSPH","BK0046","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175454812","title":"Beijing Strong Biotechnologies Secures Medical Device Registration Certificates for Five Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1175454812","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175454812?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:27","pubTimestamp":1791448021,"startTime":"0","endTime":"0","summary":"Beijing Strong Biotechnologies, Inc. (300406.SZ) has announced that the company and its wholly-owned subsidiary, Beijing Meichuang Xinyue Medical Devices Co., Ltd., recently received Medical Device...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0077","RSPH","BK0028","BK0046","BK0239","159883","IEIH","AGNG","BK0012","09996","PTH","HART","LNGR","300406","BK1583","MEDX","GDOC","BK1100","MDEV","LGHT","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113468304","title":"Centinel Spine Reports 42% Revenue Surge and Return to Profit as It Pursues U.S. IPO, Testing Valuations for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1113468304","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113468304?lang=en_us&edition=fundamental","pubTime":"2026-10-08 14:58","pubTimestamp":1791442703,"startTime":"0","endTime":"0","summary":"Centinel Spine, a well-known American medical device manufacturer, disclosed in its U.S. initial public offering filing on Wednesday local time that its first-half revenue surged 42%. The IPO...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK4127","LGHT","MDEV","MEDX","GDOC","BK1583","09996","HART","RSPH","159883","IPOS","REDS","AGNG","FRHC","PTH","BK1574","IEIH","KCE","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LU0320765489.SGD","LFSC","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BBP","BK4578","SYNB","TECB","IE00BFTCPJ56.SGD","PINK","BMED","IBB","BK4585","XLVX","MEDX","PSCH","IE0002141913.USD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","IDNA","IE0009355771.USD","NVS","MEDI","GDOC","BK4007","IYH","NVIB","LU0211331839.USD","GNMX","FRTY","MRNX","LABU","TBXU","IE00BJT1NW94.SGD","MRNY","BK4532","RSPH","PPH","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","RSPH","LU1244550221.USD","MEDI","BBP","BK4581","IE00B3S45H60.SGD","IAI","LU0267386448.USD","LU0795875169.SGD","SYNB","TBXU","LU1064131342.USD","IYH","LU0390134368.USD","BMED","IE00BZ1G4Q59.USD","KBWB","LU2023251221.USD","IDNA","GNMX","GDOC","LU2264538146.SGD","FRTY","LU2487616109.SGD","MRNY","PSCH","LABU","BK4504","LU0210528500.USD","LU1720051017.SGD","TECB","XLVX","LU0528227936.USD","BK4585","NVIB","LU0912757837.SGD","LU1720051108.HKD","MRNX","IBB","LU1668664300.SGD","LU2357305700.SGD","SD","LFSC","LU2028103732.USD","LU1791710582.SGD","LU1989772840.SGD","LU2089284900.SGD","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673931066","title":"Adherium Secures Non-Dilutive AUD$700,000 Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673931066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673931066?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:59","pubTimestamp":1791323947,"startTime":"0","endTime":"0","summary":"Adherium Ltd. ( ($AU:ADR) ) has issued an announcement. Adherium Limited, a global provider of connected respiratory medical devices and digital he...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adherium-secures-non-dilutive-aud700000-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APIE","MDTX","PINK","MEDI","GDOC","IBRN","DINT","RSPH","BMED","HRTS","FHLC","HART","ARMH","CVY","SAPH","MDEV","CURE","CROC","DIVL","LNGR","IEHS","XT","AGNG","AADR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4139","BK4604","GDOC","BK4099","CELC","TM","BK4555","BK4588","NVIB","HYLG","IDNA","BBP","IEIH","SYNB","RSPH","IBB","BK4585","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","DARP","BK4139","AGNG","IBB","RSPH","BK4588","SYNB","IE0009354923.USD","IEIH","JDOC","RNA","BK4505","BK4585","XT","BBP","FHLC","BBC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","XT","AGNG","FWD","NVIB","SYNB","BK4585","IEIH","JDOC","NANO","XBIX","FHLC","IBB","BBP","LNGR","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672632267","title":"Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672632267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672632267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:12","pubTimestamp":1790867579,"startTime":"0","endTime":"0","summary":"Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynamics Plc, a 3D genomics-focused biotechnology company listed on AIM, p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","OXM","FHLC","BK4585","BK4202","FWD","BK4588","TARK","BBP","IEIH","RSPH","IBB","DARP","GNOM","LNGR","SYNB","JDOC","XT","AGNG","BMED","GNMX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672875083","title":"Outlook submits HCPCS Level II application to CMS for J-code for LYTENAVA","url":"https://stock-news.laohu8.com/highlight/detail?id=2672875083","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672875083?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:10","pubTimestamp":1790860239,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics (OTLK) announced that it has submitted an application to the Centers for Medicare & Medicaid Services, CMS, requesting a perma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/outlook-submits-hcpcs-level-ii-application-to-cms-for-j-code-for-lytenava-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/outlook-submits-hcpcs-level-ii-application-to-cms-for-j-code-for-lytenava-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4139","OTLK","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171935778","title":"Paramount Names Kreiz as Co-CEO as Warner Bros. Deal Nears Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=1171935778","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171935778?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:10","pubTimestamp":1790809815,"startTime":"0","endTime":"0","summary":"David Ellison of Paramount Skydance Corp. said that former Mattel Inc. CEO Ynon Kreiz will become co-CEO of the combined company once the pending $110 billion acquisition of Warner Bros. Discovery...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","UYG","BK4588","CANC","PBPH","IEFN","BK4561","WMG","MNA","TBXU","BK4585","VXF","IBBQ","AAUM","PEVC","PRVT","TMED","XLFI","ACTV","BK4108","GTPE","DFMC","IYH","RFG","FFSM","BK4571","PSP","MMID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671416202","title":"Lantheus announces CMS granted TPT payment status for PYLARIFY TruVu injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2671416202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671416202?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:51","pubTimestamp":1790772680,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) Holdings announced that the Centers for Medicare & Medicaid Services, CMS, has granted Transitional Pass-Through, TPT, payment stat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantheus-announces-cms-granted-tpt-payment-status-for-pylarify-truvu-injection-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantheus-announces-cms-granted-tpt-payment-status-for-pylarify-truvu-injection-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LNGR","RSPH","LNTH","BK4585","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671462201","title":"Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2671462201","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671462201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766000,"startTime":"0","endTime":"0","summary":"SINGAPORE and NORTH BRUNSWICK, N.J., Sept.  30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371738/0/en/adlai-nortye-appoints-christopher-liu-pharmd-as-head-of-investor-relations-and-public-relations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360107325.USD","LU1854103824.USD","LU1861214812.USD","LU2298322129.HKD","JDOC","SYNB","LU1861219969.SGD","LU0348723411.USD","ALN","BBP","LU2357305700.SGD","BK4141","LU1720051108.HKD","LU1983260115.SGD","LU1861215975.USD","FHLC","LU1720051017.SGD","LU0124384867.USD","ANL","BK4585","ONX","ONG","BK4588","LU1861220033.SGD","BK4139","LU1548497426.USD","IE00BD6J9T35.USD","BK4605","IE00BFMHRM44.USD","LU0724618433.USD","IBB","LU1854104046.USD","LU1978683503.SGD","LU2133065610.SGD","RSPH","IE00BZ199S13.USD","BK4512","IEIH","ON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYX","FHLC","LLII","NBDS","ELIS","ELIL","PINK","NVOH","NVOC","CURE","PJP","THNR","NVOX","XLVI","FXH","TRUH","IYH","RSPH","MEDI","JDOC","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278331","title":"Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671278331?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:32","pubTimestamp":1790746351,"startTime":"0","endTime":"0","summary":"The latest update is out from Lonza Group Ltd ( ($CH:LONN) ). Lonza has nominated pharmaceutical and biotechnology veteran Pearl Huang as an indepe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","FWD","LNGR","XBI","BK4585","BK4588","BBP","FHLC","JDOC","DARP","BK4581","IBB","IEIH","SYNB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222612","title":"Actinogen Medical Adds Modest Number of New Shares to ASX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222612?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:17","pubTimestamp":1790738242,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, has its ordinary full...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","LNGR","FWD","RSPH","BK4585","XT","DARP","FHLC","BBP","BK4588","IEIH","JDOC","SYNB","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122851","title":"Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122851","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671122851?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:32","pubTimestamp":1790721144,"startTime":"0","endTime":"0","summary":"An update from Marvel Biosciences Corp ( ($TSE:MRVL) ) is now available. Marvel Biosciences Corp., a Calgary-based pre-clinical biotechnology compa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LNGR","BK4585","BBP","DBB","JDOC","BK4588","DARP","AGNG","FWD","SYNB","XT","IBB","RSPH","IEIH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0003},{"period":"1month","weight":-0.012},{"period":"3month","weight":0.0844},{"period":"6month","weight":0.2111},{"period":"1year","weight":0.2264},{"period":"ytd","weight":0.1617}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index (the “parent index”). The parent index is designed to measure the performance of common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (“GICS®”).","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.019074},{"month":2,"riseRate":0.5,"avgChangeRate":0.000607},{"month":3,"riseRate":0.6,"avgChangeRate":0.005438},{"month":4,"riseRate":0.55,"avgChangeRate":0.011625},{"month":5,"riseRate":0.75,"avgChangeRate":0.010785},{"month":6,"riseRate":0.5,"avgChangeRate":0.009861},{"month":7,"riseRate":0.75,"avgChangeRate":0.024438},{"month":8,"riseRate":0.6,"avgChangeRate":0.002586},{"month":9,"riseRate":0.35,"avgChangeRate":-0.009127},{"month":10,"riseRate":0.55,"avgChangeRate":-0.000842},{"month":11,"riseRate":0.789474,"avgChangeRate":0.027595},{"month":12,"riseRate":0.65,"avgChangeRate":0.012496}],"exchange":"ARCA","name":"Invesco S&P 500 Equal Weight Health Care ETF","nameEN":"Invesco S&P 500 Equal Weight Health Care ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Invesco S&P 500 Equal Weight Health Care ETF(RSPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Invesco S&P 500 Equal Weight Health Care ETF(RSPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Invesco S&P 500 Equal Weight Health Care ETF,RSPH,Invesco S&P 500 Equal Weight Health Care ETF股票,Invesco S&P 500 Equal Weight Health Care ETF股票老虎,Invesco S&P 500 Equal Weight Health Care ETF股票老虎国际,Invesco S&P 500 Equal Weight Health Care ETF行情,Invesco S&P 500 Equal Weight Health Care ETF股票行情,Invesco S&P 500 Equal Weight Health Care ETF股价,Invesco S&P 500 Equal Weight Health Care ETF股市,Invesco S&P 500 Equal Weight Health Care ETF股票价格,Invesco S&P 500 Equal Weight Health Care ETF股票交易,Invesco S&P 500 Equal Weight Health Care ETF股票购买,Invesco S&P 500 Equal Weight Health Care ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Invesco S&P 500 Equal Weight Health Care ETF(RSPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Invesco S&P 500 Equal Weight Health Care ETF(RSPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}